Nektar Therapeutics (NKTR) Research & Development (2010 - 2026)
Nektar Therapeutics (NKTR) reported Research & Development of $39.13 million for Q2 2026, up 30.9% from $29.89 million a year earlier and up 9.7% from the prior quarter.
Powered by 
Analysis
Nektar Therapeutics (NKTR) Research & Development (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Nektar Therapeutics' Research & Development came in at $131.77 million, up 6.1% year-over-year; for FY2025, it came in at $117.33 million, down 3.0% from FY2024.
- Research & Development has a five-year compound annual growth rate of -22.1% (FY2020 to FY2025).
- By year, Research & Development came in at $120.91 million in FY2024 (+5.9%), $114.16 million in FY2023 (-47.7%), $218.32 million in FY2022 (-45.5%) and $400.27 million in FY2021 (-2.1%).
- The Q2 2026 figure ranks as the highest quarterly Research & Development since Q2 2022.
- Year over year, Research & Development has now increased in each of the last three quarters, with growth averaging 10.3% over the last eight quarters.
- The high point for year-over-year Research & Development in five years was Q3 2024 (growth of 45.5%); the low point was Q1 2023 (a decline of 71.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $35.68 million (Q1 2026), $29.71 million (Q4 2025) and $27.25 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Nektar Therapeutics | 2.00 Bn | 227.61 Mn | - | 39.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39.13 Mn |
| Mar 31, 2026 | 35.68 Mn |
| Dec 31, 2025 | 29.71 Mn |
| Sep 30, 2025 | 27.25 Mn |
| Jun 30, 2025 | 29.89 Mn |
| Mar 31, 2025 | 30.48 Mn |
| Dec 31, 2024 | 28.75 Mn |
| Sep 30, 2024 | 35.03 Mn |
| Jun 30, 2024 | 29.72 Mn |
| Mar 31, 2024 | 27.41 Mn |
| Dec 31, 2023 | 29.94 Mn |
| Sep 30, 2023 | 24.07 Mn |
| Jun 30, 2023 | 29.68 Mn |
| Mar 31, 2023 | 30.47 Mn |
| Dec 31, 2022 | 34.74 Mn |
| Sep 30, 2022 | 33.59 Mn |
| Jun 30, 2022 | 42.74 Mn |
| Mar 31, 2022 | 107.25 Mn |
| Dec 31, 2021 | 99.61 Mn |
| Sep 30, 2021 | 103.74 Mn |
API Access
Nektar Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=NKTR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "NKTR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=NKTR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();